Undisclosed Cell Therapy Program
Cancer (Oncology)
PreclinicalActive
Key Facts
About Modulus Therapeutics
Modulus Therapeutics is a private, preclinical-stage biotech developing engineered immune cell therapies for cancer. Founded in 2018 and headquartered in Seattle's prominent biotech hub, the company is positioned in the rapidly evolving field of adoptive cell therapy. As a typical early-stage venture, it is pre-revenue and focused on research and platform development. Its success will hinge on translating its technological concepts into viable clinical candidates and securing substantial partnership or investment capital.
View full company profileTherapeutic Areas
Other Cancer (Oncology) Drugs
| Drug | Company | Phase |
|---|---|---|
| HemaMax | Neumedicines | Phase 2 |
| Undisclosed T Cell Program | Intune | Preclinical |
| In Vivo CAR-T Programs | GenVivo | Pre-clinical |